Sandoz Group Future Growth
Future criteria checks 3/6
Sandoz Group is forecast to grow earnings and revenue by 29.4% and 4.9% per annum respectively. EPS is expected to grow by 29.3% per annum. Return on equity is forecast to be 14.4% in 3 years.
Key information
29.4%
Earnings growth rate
29.3%
EPS growth rate
Pharmaceuticals earnings growth | 27.4% |
Revenue growth rate | 4.9% |
Future return on equity | 14.4% |
Analyst coverage | Good |
Last updated | 01 Jul 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 11,564 | 1,191 | 1,233 | 1,607 | 12 |
12/31/2025 | 10,956 | 974 | 1,020 | 1,373 | 13 |
12/31/2024 | 10,292 | 710 | 516 | 878 | 13 |
12/31/2023 | 9,979 | 77 | -258 | 362 | N/A |
9/30/2023 | 9,770 | 345 | 136 | 664 | N/A |
6/30/2023 | 9,561 | 613 | 530 | 966 | N/A |
3/31/2023 | 9,434 | 731 | 679 | 1,095 | N/A |
12/31/2022 | 9,306 | 848 | 828 | 1,223 | N/A |
12/31/2021 | 9,678 | 908 | 1,000 | 1,354 | N/A |
12/31/2020 | 9,658 | 462 | 813 | 1,098 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SDZN.Y's forecast earnings growth (29.4% per year) is above the savings rate (2.4%).
Earnings vs Market: SDZN.Y's earnings (29.4% per year) are forecast to grow faster than the US market (14.7% per year).
High Growth Earnings: SDZN.Y's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SDZN.Y's revenue (4.9% per year) is forecast to grow slower than the US market (8.6% per year).
High Growth Revenue: SDZN.Y's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SDZN.Y's Return on Equity is forecast to be low in 3 years time (14.4%).